Valid comparisons of antifibrinolytic agents used in cardiac surgery

Circulation

Volumn 115, Issue 22, 2007, Pages 2790-2792

  Bridges, Charles R ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antifibrinolytic agents; Complications; Editorials; Surgery

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; APROTININ; PLACEBO; TRANEXAMIC ACID;

ADVERSE OUTCOME; ANAPHYLAXIS; CARDIAC PATIENT; CLINICAL TRIAL; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG SAFETY; EDITORIAL; HEART INFARCTION; HEART SURGERY; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PRIORITY JOURNAL; STROKE; SURGICAL PATIENT; TREATMENT RESPONSE;

ANTIFIBRINOLYTIC AGENTS; BLOOD LOSS, SURGICAL; CARDIAC SURGICAL PROCEDURES; HUMANS; INTRAOPERATIVE PERIOD; META-ANALYSIS; RANDOMIZED CONTROLLED TRIALS; REPRODUCIBILITY OF RESULTS;

EID: 34249896187     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.706598     Document Type: Editorial

References (26)

1. Speiss BD. Transfusion and outcome in heart surgery. Ann Thorac Surg. 2002;74:986-987.
2. Ferraris VA, Ferraris SE, Saha SP, Hessel EA, Haan CK, Royston DB, Bridges CR, Higgins RSD, Despotis G, Brown JR, for the Society of Cardiovascular Anesthesiologists Special Task Force on Blood Transfusion. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Practice Guideline Series. Ann Thorac Surg. 2007;83(suppl):127-186.
3. Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med. 2006;354:353-365.
4. Mangano DT, Miao Y, Vuylsteke A, Tudor IC, Filipescu D, Hoeft A, Fontes ML, Hillel Z, Ott E, Titov T, Dietzel C, Levin J. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA. 2007;297:471-479.
5. Ferraris VA, Bridges CR, Anderson RP. Aprotinin in cardiac surgery. N Engl J Med. 2006;354:1953-1954. Letter.
6. Brown JR, Birkmeyer NJO, O'Connor GT. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Circulation. 2007;115:2801-2813.
7. Royston D, Bidstrup BP, Taylor KM, Supsford RN. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet. 1987;2:1289-1291.
8. Minami K, Notohamiprodjo G, Buschler H, Prohaska W, Reichelt W, Korfer R. Alpha-2 plasmin inhibitor-plasmin complex and postoperative blood loss: double-blind study with aprotinin in reoperation for myocardial revascularization. J Thorac Cardiovasc Surg. 1993;106:934-936.
9. Carrera A, Martinez MV, Garcia-Guiral M, Herrero E, Peral A, Planas A. Use of high doses of aprotinin in cardiac surgery. Rev Esp Anestesiol Reanim. 1994;41:13-19.
10. Rocha E, Hidalgo F, Llorens R, Melero JM, Arroyo JL, Paramo JA. Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation. 1994;60:315-320.
11. Diprose P, Herbertson MJ, O'Shaughnessy D, Deakin CD, Gill RS. Reducing allogeneic transfusion in cardiac surgery: a randomized double-blind placebo-controlled trial of antifibrinolytic therapies used in addition to intra-operative cell salvage. Br J Anaesth. 2005;4:271-278.
12. Speekenbrink RG, Vonk AB, Wildevuur CR, Eijsman L. Hemostatic efficacy of dipyridamole, tranexamic acid and aprotinin in coronary artery bypass grafting. Ann Thorac Surg. 1995;59:438-442.
13. Misfed M, Dubbert S, Eleftheriadis S, Siemens HJ, Wagner T, Sievers HH. Fibrinolysis-adjusted perioperative low-dose aprotinin reduces blood loss in bypass operations. Ann Thorac Surg. 1998;6:792-799.
14. Brown RS, Thwaites BK, Mongan PD. Tranexamic acid is effective in decreasing postoperative bleeding and transfusions in primary coronary artery bypass operations: a double-blind, randomized, placebo-controlled trial. Anesth Anag. 1997;85:963-970.
15. Blauhut B, Harringer W, Bettelheim P, Doran JE, Spath P, Lundsgaard-Hansen P. Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1994;108:1083-1091.
16. Andreasen JJ, Nielsen C. Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass. Eur J Cardiothorac Surg. 2004;6:311-317.
17. Pleym H, Stenseth R, Wahba A, Karevold A, Dale O. Single-dose tranexamic acid reduces postoperative bleeding after coronary surgery in patients treated with aspirin until surgery. Anesth Analg. 2003;96:923-928.
18. Sedrakyan A, Treasure T, Elefteriades JA. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg. 2004;28:442-448.
19. Henry DA, Moxey AJ, Carless PA. Anti-fibrinolytic use for minimizing perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2001;CD001886.
20. Karkouti K, Beattie WS, Dattilo KM, McCluskey SA, Ghannam M, Hamdy A. Wijeysundera DN, Fedorko L, Yau TM. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Transfusion. 2006;46:327-338.
21. Brown JR, Birkmeyer NJ, O'Connor GT. Aprotinin in cardiac surgery. N Engl J Med. 2006;354:1953-1957. Letter.
22. Munoz JJ, Birkmeyer NJ, Birkmeyer JD, O'Connor GT, Dacey LJ. Is epsilon-aminocaproic acid as effective as aprotinin in reducing bleeding with cardiac surgery? A meta-analysis. Circulation. 1999;99:81-89.
23. Mora Mangano CT, Neville MJ, Hsu PH. Aprotinin, blood loss, and renal dysfunction in deep hypothermic circulatory arrest. Circulation. 2001;104(suppl 1):I-276 -I-281.
24. Royston D, Chhatwani A. Safety aspects of aprotinin therapy in cardiac surgery patients. Expert Opin Drug Saf. 2006;5:539-552.
25. Beierlein W, Scheule AM, Dietrich W, Ziemer G. Forty years of clinical aprotinin use: a review of 124 hypersensitivity reactions. Ann Thorac Surg. 2005;79:741-748.
26. Alderman EL, Levy JH, Rich JB, Nili M, Vidne B, Schaff H, Uretzky G, Petterson G, Thiis JJ, Hantler CB, Chaitman B, Nadel A. Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial. J Thorac Cardiovasc Surg. 1998;116:716-730.